Skip to main content
Clinical Trials/ISRCTN65027270
ISRCTN65027270
Completed
Not Applicable

Randomized comparison of paclitaxel eluting stent versus conventional stent in ST-segment elevation myocardial infarctio

Amsterdam Department of Interventional Cardiology (ADIC) (The Netherlands)0 sites620 target enrollmentFebruary 3, 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Amsterdam Department of Interventional Cardiology (ADIC) (The Netherlands)
Enrollment
620
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2006
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Amsterdam Department of Interventional Cardiology (ADIC) (The Netherlands)

Eligibility Criteria

Inclusion Criteria

  • 1\. Acute myocardial infarction eligible for primary PCI: \>20 min of chest\-pain and at least 1 mm ST\-elevation in two contiguous leads or a new left bundle branch block
  • 2\. Reperfusion expected to be feasible within 6 hours after onset of complaints
  • 3\. Stent eligible (coronary at least 2\.5 mm) infarct related coronary artery

Exclusion Criteria

  • 1\. Age \>18 and \<80 years
  • 2\. Reperfusion not achievable within 6 hours of onset of complaints
  • 3\. Failed thrombolysis
  • 4\. Infarct related artery unsuitable for stent implantation
  • 5\. Sub\-acute stent thrombosis
  • 6\. STEMI caused by in\-stent re\-stenosis
  • 7\. Infarct related vessel/target vessel bypass graft (SVG or LIMA)
  • 8\. Contraindication for aspirin and/or clopidogrel: intolerance, allergy
  • 9\. Participation in another clinical study, interfering with this protocol
  • 10\. Cardiogenic shock prior to randomization

Outcomes

Primary Outcomes

Not specified

Similar Trials